1 / 8

Research Techniques Made Simple: Small Interfering RNA (siRNA)

Research Techniques Made Simple: Small Interfering RNA (siRNA). Vinod E. Nambudiri, MD MBA 1,2 , Rachael Clark, MD PhD 3 , Hans Widlund , PhD MSc 3 1. Harvard Combined Dermatology Residency Program, Boston, Massachusetts

amethyst-reid
Télécharger la présentation

Research Techniques Made Simple: Small Interfering RNA (siRNA)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Research Techniques Made Simple:Small Interfering RNA (siRNA) Vinod E. Nambudiri, MD MBA1,2, Rachael Clark, MD PhD3, Hans Widlund, PhD MSc3 1. Harvard Combined Dermatology Residency Program, Boston, Massachusetts 2.Department ofInternal Medicine, Brigham and Women’s Hospital, Boston, Massachusetts 3.Department ofDermatology, Brigham and Women’s Hospital, Boston, Massachusetts

  2. Processes of RNA Interference • The traditional flow of genetic information is from DNA to mRNA to protein. • RNA interference uses specifically designed RNA molecules to reduce the expression of targeted genes. • Small interfering RNAs (siRNAs) are constructed to be complementary to target mRNA sequences. • The binding of siRNAs to target mRNAs leads to the cleavage of the mRNAs and thus decreased target protein synthesis.

  3. Processes of RNA Interference • Once introduced into cells, double-stranded siRNAs are trimmed into 21- to 23-base-pair fragments. • One strand of the siRNA binds with the proteins of the RNA-induced silencing complex (RISC) in the cellular cytoplasm. • After complementary base pairing with the target mRNA, the RISC complex is activated and the mRNA transcript is cleaved. • siRNAs are a mode of posttransciptionalgene silencing.

  4. Technical Aspects of siRNA • The target gene’s DNA sequence and corresponding mRNA transcript are identified. • A series of complementary siRNAs is generated. • Once the siRNAs are synthesized as double-stranded RNAs, they must then be introduced into the cells of interest via a process known as transfection. • After the siRNAs are introduced into the cellular cytoplasm, they are able to be processed by cellular enzymes as described above and participate in the process of posttranscriptional gene silencing. • Quantification of siRNA efficacy can use techniques such as real-time reverse transcription PCR and western blotting.

  5. Summary of siRNA Gene Silencing INSERT DIAGRAM FOR FIGURE 1 HERE

  6. siRNA in Dermatology • Using siRNA to better understand and treat single-gene defect cutaneous diseases: • Dominant dystrophic epidermolysisbullosa • Epidermolysisbullosa simplex • Pachyonychiacongenita • siRNA targets mutant gene transcription products in these conditions and leads to decreased synthesis of aberrant proteins. From Pendaries et al, J Invest Dermatol 132(6):1741-3

  7. siRNA in Dermatology • siRNAs are also being studied as part of melanoma treatments by targeting proteins critical to cell proliferation, preferentially affecting cancer cells. From Zuckerman et al, J Invest Dermatol 131(2):453-60.

  8. Limitations of siRNA • Delivery of siRNAs into cells in vitro by transfection is a complex process with variable success. • Translating siRNAs for therapeutic purposes into humans is complicated by factors of appropriate delivery to target cells and stimulation of host immune responses. • Measuring and quantifying in vivo effects of therapeutic siRNA are challenging.

More Related